A groundbreaking blood test, Galleri, capable of detecting multiple cancer types in one screening, is under FDA review and could receive approval by the end of this year.
It can identify 50 types of cancer
Jun 23, 2026
06:37 pm
What's the storyThe US Food and Drug Administration (FDA) is considering the Galleri blood test as a breakthrough device for early cancer detection.
The innovative test can identify multiple types of cancer from a single blood sample.
The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it…
The Galleri test looks for fragments of DNA that have broken off a tumour and are circulating in the blood.
Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't some…
The test is ‘feasible at scale’ on the NHS, say researchers
The Galleri test, by American company GRAIL, can detect over 50 types of cancerous DNA with a simple blood test. How the cancer…
A major clinical trial involving 142,000 NHS patients revealed that the Galleri blood test for detecting over 50 cancers failed…
